NIH launches trial of investigational genital herpes vaccine

(NIH/National Institute of Allergy and Infectious Diseases) Researchers have launched an early-stage clinical trial of an investigational vaccine designed to prevent genital herpes disease. The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is sponsoring the Phase I trial, which is being conducted at the NIH Clinical Center in Bethesda, Md.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news